Form 4: Cardlytics CEO Karim Temsamani Reports Stock Transactions

Cardlytics CEO Karim Saad Temsamani reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On April 1, 2024, Karim Saad Temsamani, CEO of Cardlytics, Inc., had 50,000 restricted stock units (RSUs) vest, each representing a contingent right to receive one share of common stock.
• Following the vesting, Temsamani sold 32,564 shares on April 2, 2024, at a weighted average price of $13.69 per share.
• An additional 154 shares were sold on April 1, 2024, at a weighted average price of $14.41 per share.
• These sales were solely to satisfy withholding tax obligations resulting from the RSU vesting.
• After these transactions, Temsamani directly owns 344,580 shares of Cardlytics common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock sales to cover tax obligations.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the trading activities of company leadership.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on the stock price, but is likely insignificant given the stated reason for the sale (tax obligations).

Key Dates